HIGHLIGHTS
- who: Circulating soluble urokinase plasminogen et al. from the The study protocol was approved by the local ethics committee and conducted in accordance with the ethical standards laid down in the , Declaration of Helsinki (ethics committee of the University Hospital Aachen, RWTH-University, Aachen, Germany, reference number EK, )We enrolled , patients (, male, have published the paper: Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients, in the Journal: (JOURNAL)
- what: The authors sequentially analyzed suPAR serum concentrations . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.